Stabilux Biosciences, Inc.

Stabilux Biosciences, Inc. is a biotech startup with a mission to "Detect What Was Previously Undetectable." Founded in 2014 and headquartered in the United States, the company is a spinout from Michigan Technological University. Stabilux Biosciences has made significant strides in the biopharma and biotechnology sectors, developing proprietary NovoLux® High-Brightness Dyes™ that are 2X to 1,000X brighter than any commercial dye, thereby increasing the detection sensitivity of multi-color flow cytometry. The company, which recently received a $276.00K grant investment from the National Science Foundation in 02 September 2020, aims to unleash the next 50 years of biomedical innovation with its innovative dyes. These dyes can be integrated with existing flow cytometry equipment, enabling researchers to detect what was previously undetectable. Additionally, the novel feature of tunable brightness allows for the precise increase in brightness of a single color, enabling the detection of rare events without interfering with adjacent signals. Having leveraged $2.7M in funding and 5 years of development, Stabilux Biosciences is now poised to raise its next round of funding. The company's cutting-edge technology, impressive track record, and potential for future growth make it an exciting prospect in the biotech industry.